XOLAIR (Omalizumab) Outcomes in Pediatric Allergic Asthma Patients in the United States
Clinical trial NCT05157087 · COMPLETED
Trial details
- NCT number
- NCT05157087
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-01
- Primary completion
- 2020-12-01
- Enrollment
- 16246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.